Grace Quigley
Snr Adviser External Comms •
Sydney
Media Release: Clayton Utz advises NSW Government on new company to operate world-leading viral vector manufacturing facility
1 minute
Clayton Utz has advised NSW Government on the establishment of a new company to operate the world-leading viral vector manufacturing facility based at Westmead, which will secure viral vector supply for Australian researchers and give patients access to groundbreaking therapies.
The NSW Government has committed $134.5 million to establish the facility and to manufacture viral vector products for research and clinical trials.
Partner David Wilkie led the Clayton Utz team alongside Director Strategic Corp/M&A Rod Halstead, Partners John Collins, Amanda Lyras, Stuart Cosgriff and Dr Ashley Tsacalos and Senior Associate Francis Yuan.
David says it was a pleasure to assist NSW Government on reaching this significant milestone.
We are delighted to have supported NSW Government in establishing a world-leading viral vector manufacturing facility, the first of its kind in Australia – the facility at the Westmead precinct will position New South Wales and Australia as a leader in future health research and innovation, promoting a culture of medical research and modern manufacturing.
Get in touch
Disclaimer
Clayton Utz communications are intended to provide commentary and general information. They should not be relied upon as legal advice. Formal legal advice should be sought in particular transactions or on matters of interest arising from this communication. Persons listed may not be admitted in all States and Territories.